Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 50228-384

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 50228-384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine Fumarate 150 mg 60 Count Label (Quetiapine 150mg)

Each tablet contains 172.7 mg of Quetiapine Fumarate, equivalent to 150 mg of Quetiapine. The recommended usual dosage is once daily. It is an Extended-Release tablet. The medication should be stored at 25°C (77°), within the permitted excursions of 0-15°C or 0-30°C. From Tampere, Finland. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. Dispense the accompanying medication guide to each patient. Manufactured by ScieGen Pharmaceuticals in Hauppauge, NY. There is no prescribing information available.*

FDA Label Image

Quetiapine Fumarate 200 mg 60 Count Label (Quetiapine 200mg)

This is a medication description for Quetiapine tablets manufactured by ScieGen Pharmaceuticals Inc. Each tablet contains 230.26 mg of Quetiapine Fumarate equivalent to 200 mg of Quetiapine. The tablets should be swallowed whole and not split, crushed, or chewed. The recommended dosage is once per day as per accompanying prescribing information. Store the medicine at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication is Rx only and must be kept out of the reach of children. The product comes with a medication guide for patients. The release type of the medication is extended.*

FDA Label Image

Quetiapine Fumarate 300 mg 60 Count Label (Quetiapine 300mg)

This is a medication description for Quetiapine Fumarate Extended-Release tablets. Each tablet contains 345.38 mg of NDC 50228-383-60 and is equivalent to 300 mg of quetiapine. It is recommended to take one tablet daily, with storage allowed at 25°C (77°F) and excursion permitted from 15°C to 30°C. It is essential to keep this and all medications out of reach of children, and the accompanying medication guide should be dispensed to each patient. The manufacturer of this medication is ScieGen, and the medication is sold in a container with 60 tablets.*

FDA Label Image

Quetiapine Fumarate 400 mg 60 Count Label (Quetiapine 400mg)

This is a medication containing quetiapine fumarate, with each tablet containing 460.5mg of NDC 50228-384-60, equivalent to 400mg of quetiapine. It is taken once daily as an extended-release tablet. Storage instructions indicate that it should be kept at a temperature range of 15°C to 30°C. The manufacturer is ScieGen Pharmaceutical, Inc. A Medication Guide is included with the tablets, and it should be kept out of the reach of children.*

FDA Label Image

Quetiapine Fumarate 50 mg 30 Count Bottle Label (Quetiapine 50mg)

Each tablet contains 57.56 mg of Quetiapine Fumarate (equivalent to 50 mg of Quetiapine). These are extended-release tablets that are stored at a temperature range of 15-30°C. The medication should be kept out of reach of children, and the accompanying medication guide should be dispensed to each patient. Manufactured by ScieGen Pharmaceuticals, Inc. This is a prescription drug with 60 tablets.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Fig01)

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Fig02)

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Fig03)

FDA Label Image

Structural Formula (Quetiapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.